STIM

William Andrew MacAn

Known title: Sr. VP, GC, CCO and SecretaryCIK: 0001758584

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 15, 2026

STIM shifts focus from devices to psychedelic infrastructure. Neuronetics announced it is moving away from solely manufacturing its TMS device and is building a platform to support psychedelic therapies. The change aims to broaden the company's role in the emerging mental-health market. The stock is currently trading near its $1.19 support level and has an RSI of 25.4, indicating a low momentum environment.

this person other insiders at STIM

Transaction History

STIM▼ Sell$21K
STIM▲ Buy$0
STIM▼ Sell$816
STIM▼ Sell$5K
STIM▲ Buy$0
STIM▼ Sell$23K
STIM▼ Sell$5K
STIM▲ Buy$0
STIM▼ Sell$2K
STIM▲ Buy$0
STIM▼ Sell$78K
STIM▼ Sell$47K
STIM▼ Sell$6K
STIM▼ Sell$1K
STIM▲ Buy$0
STIM▼ Sell$18K
STIM▼ Sell$71K
STIM▼ Sell$53K
STIM▼ Sell$18K
STIM▲ Buy$0
STIM▼ Sell$29K
STIM▼ Sell$31K
STIM▼ Sell$26K
STIM▼ Sell$2K
STIM▼ Sell$6K
STIM▼ Sell$58K
STIM▼ Sell$65K
STIM▼ Sell$71K
STIM▲ Buy$0
STIM▼ Sell$31K
STIM▼ Sell$96K
STIM▼ Sell$214
STIM▼ Sell$5K
STIM▼ Sell$10K
STIM▼ Sell$430
STIM▼ Sell$33K
STIM▲ Buy$0
STIM▼ Sell$49
STIM▼ Sell$15K
STIM▼ Sell$41K
STIM▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.